Dendron lipids designed to consist of amine-terminated polyamidoamine G1 dendron and two octadecyl chains were used for the preparation of pH-responsive molecular assemblies having phase structures that are changed through their dynamic molecular shape. The dendron lipid contains two primary amines and two tertiary amines in the dendron moiety, changing its charged state in the pH region between pH 10 and pH 4. The assemblies were shown to take a vesicle structure at neutral and alkaline pHs, but their structure changed to a micelle-like structure below pH 6.4. Because this pH region corresponds to one in which tertiary amines of the dendron lipid became protonated, protonation of tertiary amines in addition to primary amines in the dendron moiety might affect its dynamic molecular shape, resulting in a sharp pH response of the assemblies. The assemblies tended to form aggregates when taking on a vesicle form with a gel phase, but incorporation of a poly(ethylene glycol)-lipid provided dendron lipid vesicles with both sharp pH response and high colloidal stability. The poly(ethylene glycol)-incorporated dendron lipid vesicles tightly retained ovalbumin molecules in their internal aqueous space but released them almost completely at pH 6.0. In addition, the vesicles were shown to achieve efficient ovalbumin delivery into cytosol of DC2.4 cells (mouse dendritic cell line) after internalization through endocytosis.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.langmuir.5b00183DOI Listing

Publication Analysis

Top Keywords

dendron lipid
20
tertiary amines
12
amines dendron
12
dendron
8
dynamic molecular
8
molecular shape
8
primary amines
8
dendron moiety
8
sharp response
8
lipid vesicles
8

Similar Publications

Impact of nanoparticle properties on immune cell interactions in the lymph node.

Acta Biomater

December 2024

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 399 Royal Parade, Parkville, VIC 3052, Australia. Electronic address:

The lymphatic system plays an important role in health and many diseases, such as cancer, autoimmune, cardiovascular, metabolic, hepatic, viral, and other infectious diseases. The lymphatic system is, therefore, an important treatment target site for a range of diseases. Lymph nodes (LNs), rich in T cells, B cells, dendritic cells, and macrophages, are also primary sites of action for vaccines and immunotherapies.

View Article and Find Full Text PDF

Four-component lipid nanoparticles (LNPs) and viral vectors are key for mRNA vaccine and therapeutics delivery. LNPs contain ionizable lipids, phospholipids, cholesterol, and polyethylene glycol (PEG)-conjugated lipids and deliver mRNA for COVID-19 vaccines to liver when injected intravenously or intramuscularly. In 2021, we elaborated one-component ionizable amphiphilic Janus dendrimers (IAJDs) accessing targeted delivery of mRNA.

View Article and Find Full Text PDF

Phytochemicals as dietary components are being extensively explored in order to prevent and treat a wide range of diseases. Apigenin is among the most studied flavonoids found in significant amount in fruits (oranges), vegetables (celery, parsley, onions), plant-based beverages (beer, tea, wine) and herbs (thyme, chamomile, basil, oregano) that has recently gained interest due to its promising pharmacological effects. However, the poor solubility and extended first pass metabolism of apigenin limits its clinical use.

View Article and Find Full Text PDF

Innovative gene delivery systems for retinal disease therapy.

Neural Regen Res

December 2024

Department of Ophthalmology, Songjiang Hospital and Songjiang Research Institute, Shanghai Key Laboratory of Emotions and Affective Disorders, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Article Synopsis
  • The human retina has various specialized cells that work together to transmit visual signals, but genetic and age-related issues can lead to serious vision impairment or blindness.
  • Current treatment options for retinal diseases are limited, highlighting the need for new therapeutic strategies, particularly cell and gene therapies that target retinal cells.
  • Two main types of gene delivery systems—viral (like lentiviruses and adeno-associated viruses) and non-viral (such as liposomal technology)—are being explored for effectively delivering therapeutic genes to treat retinal diseases, each with its unique advantages and limitations.
View Article and Find Full Text PDF
Article Synopsis
  • * The article reviews the limitations of current therapies and explores various nanoparticle (NP) based approaches for treating HCC, highlighting types like liposomes and carbon nanotubes.
  • * It emphasizes the effectiveness of NP technologies in photothermal and photodynamic therapies, while also discussing recent patents and clinical studies that show promise for enhancing treatment outcomes for HCC.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!